Trial intelligence / Profile preview

Plasma Bupivacaine in Children with TIVA vs Volatile Anaesthesia

NCT01216007Phase 2Completed

Sponsor
University of British Columbia
Start
Oct 2010
Primary completion
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of bupivacaine hydrochloride 0.75% injection in pain, sponsored by University of British Columbia. Started Oct 2010; status: completed.

02

Drugs

bupivacaine hydrochloride 0.75% injection
03

Conditions

pain

Beyond the preview

Go deeper on NCT01216007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01216007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call